| 1H2K |
2.15 |
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
| 1H2L |
2.25 |
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
| 1H2M |
2.5 |
Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
| 1H2N |
2.84 |
Factor Inhibiting HIF-1 alpha |
| 1IZ3 |
2.8 |
Dimeric structure of FIH (Factor inhibiting HIF) |
| 1MZE |
2.2 |
Human Factor Inhibiting HIF (FIH1) |
| 1MZF |
2.4 |
Human Factor inhibiting HIF (FIH1) in Complex with 2-oxoglutarate |
| 1YCI |
2.7 |
Factor inhibiting HIF-1 alpha in complex with N-(carboxycarbonyl)-D-phenylalanine |
| 2CGN |
2.4 |
FACTOR INHIBITING HIF-1 ALPHA with succinate |
| 2CGO |
2.3 |
FACTOR INHIBITING HIF-1 ALPHA with fumarate |
| 2ILM |
2.3 |
Factor Inhibiting HIF-1 Alpha D201A Mutant in Complex with FE(II), Alpha-Ketoglutarate and HIF-1 Alpha 35mer |
| 2W0X |
2.12 |
FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID |
| 2WA3 |
2.5 |
FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3-hydroxyphenyl)-2-oxoacetic acid |
| 2WA4 |
2.5 |
FACTOR INHIBITING HIF-1 ALPHA WITH N,3-dihydroxybenzamide |
| 2XUM |
2.2 |
FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), NOG AND ASP-SUBSTRATE PEPTIDE (20-MER) |
| 2Y0I |
2.28 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH TANKYRASE-2 (TNKS2) FRAGMENT PEPTIDE (21-MER) |
| 2YC0 |
2.15 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH R-2-HYDROXYGLUTARATE |
| 2YDE |
2.28 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH S-2-HYDROXYGLUTARATE |
| 3D8C |
2.1 |
Factor inhibiting HIF-1 alpha D201G mutant in complex with ZN(II), alpha-ketoglutarate and HIF-1 alpha 19mer |
| 3KCX |
2.6 |
Factor inhibiting HIF-1 alpha in complex with Clioquinol |
| 3KCY |
2.59 |
Factor inhibiting HIF-1 alpha in complex with 8-hydroxyquinoline |
| 3OD4 |
2.2 |
Crystal Structure of Factor Inhibiting HIF-1 Alpha Complexed with Inhibitor |
| 3P3N |
2.4 |
Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1930-1949) peptide |
| 3P3P |
2.6 |
Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1997-2016) peptide |
| 4AI8 |
2.4 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH DAMINOZIDE |
| 4B7E |
2.5 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-LEU PEPTIDE (20-MER) |
| 4B7K |
2.39 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-SER PEPTIDE (20-MER) |
| 4BIO |
2.45 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH 8-HYDROXYQUINOLINE-5- CARBOXYLIC ACID |
| 4JAA |
2.39 |
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)LEU peptide |
| 4NR1 |
2.68 |
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)allyl-GLY peptide |
| 4Z1V |
2.1 |
Structure of Factor Inhibiting HIF (FIH) in complex with Fe, NO, and NOG |
| 4Z2W |
2.5 |
Factor Inhibiting HIF in Complex with Fe, and Alpha-Ketoglutarate |
| 5JWK |
2.3 |
Factor Inhibiting HIF D201E in Complex with Fe, and Alpha-Ketoglutarate |
| 5JWL |
2.4 |
Factor Inhibiting HIF D201E in Complex with Zn, and Alpha-Ketoglutarate |
| 5JWP |
2.1 |
Crystal structure of human FIH D201E variant in complex with Zn, alpha-ketoglutarate, and HIF1 alpha peptide. |
| 5OP6 |
2.45 |
Factor Inhibiting HIF (FIH) in complex with zinc and GSK128863 |
| 5OP8 |
2.3 |
Factor Inhibiting HIF (FIH) in complex with zinc and Molidustat |
| 5OPC |
2.3 |
Factor Inhibiting HIF (FIH) in complex with zinc and Vadadustat |
| 6H9J |
1.83 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (229-255) |
| 6HA6 |
1.98 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (220-246) |
| 6HC8 |
1.9 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPA1 (313-339) |
| 6HKP |
1.9 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP2 (970-992) |
| 6HL5 |
1.98 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP1(932-954) |
| 6HL6 |
1.97 |
Factor Inhibiting HIF (FIH) in complex with zinc, NOG and iASPP(670-693) |
| 6RUJ |
2.42 |
Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)3-hydroxy-Leu peptide |
| 7A1J |
1.9 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-(3-phenylpropyl)-2-oxoglutarate |
| 7A1K |
1.99 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-((9,9-dimethyl-9H-fluoren-2-yl)methyl)-2-oxoglutarate |
| 7A1L |
2.29 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-methyl-2-oxoglutarate |
| 7A1M |
2.18 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-propyl-2-oxoglutarate |
| 7A1N |
2.01 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND CONSENSUS ANKYRIN REPEAT DOMAIN (20-MER) |
| 7A1O |
2.21 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-ethyl-2-oxoglutarate, AND CONSENSUS ANKYRIN REPEAT DOMAIN (20-MER) |
| 7A1P |
1.76 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-propyl-2-oxoglutarate, AND CONSENSUS ANKYRIN REPEAT DOMAIN (20-MER) |
| 7A1Q |
1.75 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-(carboxycarbonyl)cyclopentane-1-carboxylic acid, AND CONSENSUS ANKYRIN REPEAT DOMAIN (20-MER) |
| 7A1S |
2.01 |
FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND TANKYRASE-2 (TNKS2) FRAGMENT PEPTIDE (21-MER) |
